Crewe Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7K Sell
777
-84
-10% -$5.52K ﹤0.01% 436
2026
Q1
$61.3K Buy
861
+18
+2% +$1.42K 0.01% 358
2025
Q4
$69.1K Hold
843
0.01% 327
2025
Q3
$63.3K Hold
843
0.01% 349
2025
Q2
$62.4K Sell
843
-66
-7% -$4.59K 0.01% 270
2025
Q1
$73.4K Hold
909
0.01% 233
2024
Q4
$71.1K Sell
909
-171
-16% -$14.5K 0.01% 246
2024
Q3
$101K Hold
1,080
0.01% 229
2024
Q2
$84.2K Buy
1,080
+5
+0.5% +$408 0.01% 297
2024
Q1
$97.7K Buy
+1,075
New +$89.4K 0.01% 276
2023
Q3
Sell
-860
Closed -$69.9K 712
2023
Q2
$69.9K Buy
860
+2
+0.2% +$160 0.01% 240
2023
Q1
$70.4K Buy
+858
New +$61.3K 0.01% 269

Other funds holding GEHC

Crewe Advisors's GEHC Position: Q2 2026 in Review

Crewe Advisors reduced its GE HealthCare (GEHC) stake by 9.8% in Q2 2026, selling an estimated $5.52K and leaving 777 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Crewe Advisors first reported a position in GEHC in Q1 2023 and has held it in 12 quarters since. The position peaked at $101K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Crewe Advisors held 777 shares of GE HealthCare worth $49.7K as of Q2 2026.
  • Crewe Advisors sold 84 GE HealthCare shares in Q2 2026, an estimated $5.52K.
  • GE HealthCare made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #436 holding.
  • Crewe Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 12 quarters since.
  • Crewe Advisors's GE HealthCare position peaked at $101K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.